Immunological heterogeneity in rheumatoid arthritis: challenges in early-stage stratification, non-response to targeted therapy, and the restoration of immune tolerance - Poll - MDSpire

Immunological Diversity in Rheumatoid Arthritis: Addressing Early Stratification Challenges, Targeted Therapy Non-Response, and Immune Tolerance Restoration

  • By

  • Yanmei Li

  • Kairui Zhu

  • Yushan Ding

  • Dongyang Wu

  • Yulong Mu

  • Xiaoke Liu

  • Xuelin Liu

  • Xinran Yu

  • Yuhan Yan

  • Yunxiao Sun

  • Youjie Li

  • July 20, 2026

Share

Original Source(s)

Immunological heterogeneity in rheumatoid arthritis: challenges in early-stage stratification, non-response to targeted therapy, and the restoration of immune tolerance

  • by Yanmei Li, Kairui Zhu, Yushan Ding, Dongyang Wu, Yulong Mu, Xiaoke Liu, Xuelin Liu, Xinran Yu, Yuhan Yan, Yunxiao Sun, Youjie Li

  • July 20, 2026

Related Content

Immune network dysregulation in rheumatoid arthritis and systemic lupus erythematosus: cytokine signatures, autoantibody profiles, and implications for precision medicine

Correction: Postpartum-onset anti-PM/Scl–positive dermatomyositis–systemic sclerosis overlap syndrome with reversible interstitial lung disease: a case report

Biomarkers of treatment response in rheumatoid arthritis: from conventional markers to tissue immunophenotype